Healthcare stocks experienced a downturn due to negative developments, including analyst downgrades and lost lawsuits. Companies like Elevance Health and Humana saw declines. Pharmaceutical and biotech companies also suffered losses, with Sarepta Therapeutics and GSK facing challenges. Concerns about rising costs and inadequate pricing for 2025 plans added to the pressure. Amphastar Pharmaceuticals saw volatility, impacted by broader market sentiment and trade tensions with Canada. The healthcare sector faced challenges from U.S. policy headwinds and corporate issues. The Health Care SPDR ETF fell 1.0%, underperforming major indices. Amphastar Pharmaceuticals is down 43.4% since the beginning of the year.

Read more at StockStory: agilon health, LifeStance Health Group, The Pennant Group, Corcept, and Amphastar Pharmaceuticals Shares Plummet, What You Need To Know